487 related articles for article (PubMed ID: 35172843)
1. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease.
Pike AF; Longhena F; Faustini G; van Eik JM; Gombert I; Herrebout MAC; Fayed MMHE; Sandre M; Varanita T; Teunissen CE; Hoozemans JJM; Bellucci A; Veerhuis R; Bubacco L
J Neuroinflammation; 2022 Feb; 19(1):50. PubMed ID: 35172843
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary human microglia.
Pike AF; Varanita T; Herrebout MAC; Plug BC; Kole J; Musters RJP; Teunissen CE; Hoozemans JJM; Bubacco L; Veerhuis R
Glia; 2021 Jun; 69(6):1413-1428. PubMed ID: 33506583
[TBL] [Abstract][Full Text] [Related]
3. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
[TBL] [Abstract][Full Text] [Related]
5. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
Gordon R; Albornoz EA; Christie DC; Langley MR; Kumar V; Mantovani S; Robertson AAB; Butler MS; Rowe DB; O'Neill LA; Kanthasamy AG; Schroder K; Cooper MA; Woodruff TM
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381407
[TBL] [Abstract][Full Text] [Related]
6. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
7. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
8. HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson's disease.
Wang HL; Cheng YC; Yeh TH; Liu HF; Weng YH; Chen RS; Chen YC; Lu JC; Hwang TL; Wei KC; Liu YC; Wang YT; Hsu CC; Chiu TJ; Chiu CC
Biochem Pharmacol; 2023 Jun; 212():115524. PubMed ID: 37001680
[TBL] [Abstract][Full Text] [Related]
9. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
[TBL] [Abstract][Full Text] [Related]
10. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
11. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
[TBL] [Abstract][Full Text] [Related]
12. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
[TBL] [Abstract][Full Text] [Related]
13. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q
Front Immunol; 2021; 12():794770. PubMed ID: 34925379
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice.
Ou Z; Zhou Y; Wang L; Xue L; Zheng J; Chen L; Tong Q
Mol Neurobiol; 2021 Apr; 58(4):1303-1311. PubMed ID: 33169332
[TBL] [Abstract][Full Text] [Related]
15. Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation.
Hou L; Liu J; Sun F; Huang R; Chang R; Ruan Z; Wang Y; Zhao J; Wang Q
J Neuroinflammation; 2023 Feb; 20(1):42. PubMed ID: 36804009
[TBL] [Abstract][Full Text] [Related]
16. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
17. Echinacoside exerts neuroprotection via suppressing microglial α-synuclein/TLR2/NF-κB/NLRP3 axis in parkinsonian models.
Yang XP; Huang JH; Ye FL; Yv QY; Chen S; Li WW; Zhu M
Phytomedicine; 2024 Jan; 123():155230. PubMed ID: 38000105
[TBL] [Abstract][Full Text] [Related]
18. Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease.
Haque ME; Akther M; Jakaria M; Kim IS; Azam S; Choi DK
Mov Disord; 2020 Jan; 35(1):20-33. PubMed ID: 31680318
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3.
Zhu J; Hu Z; Han X; Wang D; Jiang Q; Ding J; Xiao M; Wang C; Lu M; Hu G
Cell Death Differ; 2018 Nov; 25(11):2037-2049. PubMed ID: 29786071
[TBL] [Abstract][Full Text] [Related]
20. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
